CTLA4 and neoplasm: Meanwhile, Du et al. have reported the generation of an oAd (SKL002) with an anti-CTLA4 Ab gene inserted into the E3 region of the viral genome with anti-tumor efficacy in both in vitro and in vivo models [85].